discovered that PD-L1 expressing tumor-associated macrophages (TAMs) are predominantly situated in the peritumoral area of HCC, and that blocking PD-L1 expression on macrophages could potentially restore the function of CD8+ and CD4+ T cells, hence improving the efficacy of immunotherapy (35). The gene discussed is CD4; the disease is hepatocellular carcinoma.